Literature DB >> 19937113

HIV-1 integrase and virus and cell DNAs: complex formation and perturbation by inhibitors of integration.

Z Hobaika1, L Zargarian, R G Maroun, O Mauffret, T R Burke, S Fermandjian.   

Abstract

HIV-1 integrase (IN) catalyzes integration of viral DNA into cell DNA through 3'-processing of viral DNA and strand transfer reactions. To learn on binding of IN to DNAs and IN inhibition we applied spectroscopy (circular dichroism, fluorescence) in a simplified model consisting in a peptide analogue (K156) of alpha4 helix involved in recognition of viral and cell DNA; an oligonucleotide corresponding to the U5' LTR DNA end; and an inhibitor (TB11) of the diketo acid (DKA) family. Results extrapolated to IN show that: the enzyme binds viral DNA with high affinity and specificity, but cell DNA with low affinity and specificity; the affinity of TB11 for IN is high enough to impair the binding of IN to cell DNA, but not to viral DNA. This explains why TB11 is an inhibitor of strand transfer but not of 3'-processing. These results can help in the search of new IN inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937113      PMCID: PMC7386435          DOI: 10.1007/s11064-009-0098-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.

Authors:  M Cai; R Zheng; M Caffrey; R Craigie; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1997-07

2.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Environment affects amino acid preference for secondary structure.

Authors:  L Zhong; W C Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Crystal structure of a Src-homology 3 (SH3) domain.

Authors:  A Musacchio; M Noble; R Pauptit; R Wierenga; M Saraste
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

Review 5.  Integrase inhibitors to treat HIV/AIDS.

Authors:  Yves Pommier; Allison A Johnson; Christophe Marchand
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

6.  X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.

Authors:  Z Chen; Y Yan; S Munshi; Y Li; J Zugay-Murphy; B Xu; M Witmer; P Felock; A Wolfe; V Sardana; E A Emini; D Hazuda; L C Kuo
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

7.  Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors.

Authors:  Xuechun Zhang; Godwin C G Pais; Evguenia S Svarovskaia; Christophe Marchand; Allison A Johnson; Rajeshri G Karki; Marc C Nicklaus; Vinay K Pathak; Yves Pommier; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2003-03-24       Impact factor: 2.823

8.  Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.

Authors:  Max Lataillade; Jennifer Chiarella; Michael J Kozal
Journal:  Antivir Ther       Date:  2007

9.  Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S).

Authors:  Christophe Marchand; Allison A Johnson; Rajeshri G Karki; Godwin C G Pais; Xuechun Zhang; Kiriana Cowansage; Tapan A Patel; Marc C Nicklaus; Terrence R Burke; Yves Pommier
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

10.  Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase.

Authors:  Jean-Guillaume Renisio; Sylvain Cosquer; Ilham Cherrak; Saïd El Antri; Olivier Mauffret; Serge Fermandjian
Journal:  Nucleic Acids Res       Date:  2005-04-06       Impact factor: 16.971

View more
  4 in total

Review 1.  SARS-CoV-2: Molecular Structure, Pathogenesis, Potential Therapeutic Targets, and Immune Response of the Infected Subject.

Authors:  R Wumba; M Mandina; Y Nlandu; J R Makulo; A Tshimpi; P Mbala; A Mbangama; P Kabututu; J M Kayembe
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-06-02

2.  The HIV-1 integrase α4-helix involved in LTR-DNA recognition is also a highly antigenic peptide element.

Authors:  Sandy Azzi; Vincent Parissi; Richard G Maroun; Pierre Eid; Olivier Mauffret; Serge Fermandjian
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

3.  Unprocessed viral DNA could be the primary target of the HIV-1 integrase inhibitor raltegravir.

Authors:  Farah F Ammar; Safwat Abdel-Azeim; Loussinée Zargarian; Zeina Hobaika; Richard G Maroun; Serge Fermandjian
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

4.  A targeted DNA substrate mechanism for the inhibition of HIV-1 integrase by inhibitors with antiretroviral activity.

Authors:  Farah F Ammar; Zeina Hobaika; Safwat Abdel-Azeim; Loussinée Zargarian; Richard G Maroun; Serge Fermandjian
Journal:  FEBS Open Bio       Date:  2016-02-24       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.